Skip to content
TrialScanner

NCT06939283

A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma

Phase 1/Phase 2CompletedHOWLLead

Registry record

Lead sponsor
Werewolf Therapeutics, Inc.
Conditions
Advanced or Metastatic Solid Tumors; Non-Hodgkin Lymphoma
Primary completion
Apr 23, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06939283 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06939283: A Phase 1b/2 Multisite... | TrialScanner